ЭФФЕКТИВНОСТЬ НЕЛИПОФИЛЬНЫХ ИНГИБИТОРОВ АНГИОТЕНЗИН-ПРЕВРАЩАЮЩЕГО ФЕРМЕНТА В ЛЕЧЕНИИ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ
Аннотация
Эффективность нелипофильных ингибиторов ангиотензин-превращающего фермента в лечении сердечно-сосудистых заболеваний.
Список литературы
1. Campbell D.J., Kladis A., Duncan A.M. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertens. 1994; 23: 439-49.
2. Yesil S., Yesil M., Bayata S., Postaci N. ACE inhibitors and lough. Angiology 1994; 45(9): 805-8.
3. Lancaster S.G., Todd P.A. Lisinopril: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension and congestive heart failure. Drugs 1988; 35: 646-69.
4. Gissi-3 Investigators Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acate myocardial infarction: the Gissi-3 trial. J. Am. Coll Cardiol. 1996; 27: 337-44.
5. Packer M., Poole-Wilson P.A., Armstrong P., et al. Comperative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation. 1999; 100: 1-7.
6. Hansson L., Lindholm L.H., Ekbom T., et al. Randomised trial of old and new antihypertensive drugs in eldery patients: cardiovascular mortality and morbility the Swidish Trial in Old Patients with Hypertension-2 Study. Lancet. 1999: 354: 1751-6.
7. ALLHAT Authors. Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme inhibitor or Calcium channel blocker VS Diuretic. JAMA. 2002 Dec 18; 288(23): 2981-97.
8. Laviades C., Mayor G., Diez J. Treatment with lisinopril normalizes serum concentrations of procollagen type III amineterminal peptide in patients with essential hypertension. Am. J. Hypertens. 1994; 7(1): 52-8.
9. TROPHY study Group. Lisinopril versus HCTZ in obese hypertensive patients: a multicenter placebo-controlled trial. Hypertens. 1997; 30: 140-45.
10. EUCLID study Group. Randomized placebo controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet. 1997; 349: 1787-92.
Рецензия
Для цитирования:
Мазур Н.А. ЭФФЕКТИВНОСТЬ НЕЛИПОФИЛЬНЫХ ИНГИБИТОРОВ АНГИОТЕНЗИН-ПРЕВРАЩАЮЩЕГО ФЕРМЕНТА В ЛЕЧЕНИИ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ. Российский кардиологический журнал. 2003;(4):76-79.
For citation:
Mazur N.A. EFFICACY OF A NON-LIPOPHILIC ANGIOTENSIN CONVERTING ENZYME INHIBITOR AND ITS POSSIBLE ADVANTAGES. Russian Journal of Cardiology. 2003;(4):76-79. (In Russ.)
Просмотров:
271
Послать статью по эл. почте 